|
|||||
|
|

Hair care company Olaplex (NASDAQ:OLPX) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 3.8% year on year to $114.6 million. The company expects the full year’s revenue to be around $420.5 million, close to analysts’ estimates. Its GAAP profit of $0.02 per share was $0.02 above analysts’ consensus estimates.
Is now the time to buy OLPX? Find out in our full research report (it’s free for active Edge members).
Olaplex’s third quarter results reflected the early impact of its strategic shift toward coordinated marketing and product innovation. While revenue declined year on year, management credited improvements in sell-through trends to the launch of its new hair masks and a fully integrated 360-degree marketing campaign. CEO Amanda Baldwin noted that these efforts marked “progress in our transformational journey,” and emphasized that the company’s investments in brand health and scientific storytelling are already creating stronger consumer connections. Performance across professional channels was supported by targeted promotions and education, while specialty retail and direct-to-consumer segments continued to experience expected softness.
Looking forward, Olaplex’s guidance is anchored in continued brand investment, targeted international expansion, and a disciplined approach to product innovation. Management highlighted that upcoming product launches, along with the acquisition of Purvala Bioscience, are expected to fuel the company’s R&D pipeline and support long-term growth. CFO Catherine Dunleavy acknowledged ongoing macroeconomic headwinds and an uncertain holiday environment, but reiterated a focus on executing against controllable levers. Baldwin stated, “We are building a platform that balances immediate innovation with bigger, longer-term bets,” signaling that both near-term marketing activations and foundational scientific advances will shape future performance.
Management identified coordinated product launches, brand-building efforts, and improved professional partnerships as key factors influencing the quarter’s results and the company’s outlook.
Management’s outlook centers on balancing ongoing investment in brand and innovation with operational discipline amid market uncertainty.
In the quarters ahead, our analysts are tracking (1) the performance of Olaplex’s new products and subsequent launches to gauge sustained consumer demand, (2) the ongoing impact of international market investments and realignment on overall sales momentum, and (3) the ability of professional and direct-to-consumer channels to stabilize or grow despite category-wide promotional pressures. Execution on innovation and brand-building initiatives will remain key markers of progress.
Olaplex currently trades at $1.09, up from $1.07 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free for active Edge members).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| 4 hours | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 | |
| Nov-04 | |
| Oct-31 | |
| Oct-30 | |
| Oct-29 | |
| Oct-23 | |
| Oct-13 | |
| Oct-08 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite